185 related articles for article (PubMed ID: 11074181)
21. Efficacy and safety of pregabalin versus levetiracetam as adjunctive therapy in patients with partial seizures: a randomized, double-blind, noninferiority trial.
Zaccara G; Almas M; Pitman V; Knapp L; Posner H
Epilepsia; 2014 Jul; 55(7):1048-57. PubMed ID: 24902473
[TBL] [Abstract][Full Text] [Related]
22. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
[TBL] [Abstract][Full Text] [Related]
23. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures.
Glauser TA; Ayala R; Elterman RD; Mitchell WG; Van Orman CB; Gauer LJ; Lu Z;
Neurology; 2006 Jun; 66(11):1654-60. PubMed ID: 16641323
[TBL] [Abstract][Full Text] [Related]
24. [Levetiracetam in the treatment of epilepsy].
Mariero Klees T; Brodtkorb E; Nakken KO; Lossius R; Johannessen SI
Tidsskr Nor Laegeforen; 2003 May; 123(11):1539-41. PubMed ID: 12822020
[TBL] [Abstract][Full Text] [Related]
25. Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures.
Noachtar S; Andermann E; Meyvisch P; Andermann F; Gough WB; Schiemann-Delgado J;
Neurology; 2008 Feb; 70(8):607-16. PubMed ID: 18285535
[TBL] [Abstract][Full Text] [Related]
26. Levetiracetam. A review of its adjunctive use in the management of partial onset seizures.
Dooley M; Plosker GL
Drugs; 2000 Oct; 60(4):871-93. PubMed ID: 11085199
[TBL] [Abstract][Full Text] [Related]
27. Pregabalin or placebo used adjunctively with levetiracetam in refractory partial-onset epilepsy: a post hoc efficacy and safety analysis in combined clinical trials.
Uthman BM; Almas M; Emir B; Giordano S; Leon T
Curr Med Res Opin; 2011 Jul; 27(7):1285-93. PubMed ID: 21561392
[TBL] [Abstract][Full Text] [Related]
28. Levetiracetam as add-on therapy for idiopathic generalized epilepsy syndromes with onset during adolescence: analysis of two randomized, double-blind, placebo-controlled studies.
Rosenfeld WE; Benbadis S; Edrich P; Tassinari CA; Hirsch E
Epilepsy Res; 2009 Jul; 85(1):72-80. PubMed ID: 19327967
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of levetiracetam as adjunctive therapy in Japanese patients with uncontrolled partial-onset seizures.
Inoue Y; Yagi K; Ikeda A; Sasagawa M; Ishida S; Suzuki A; Yoshida K;
Psychiatry Clin Neurosci; 2015 Oct; 69(10):640-8. PubMed ID: 25854635
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of levetiracetam as an add-on therapy in children aged less than 4 years with refractory epilepsy.
Li S; Cao J; Xiao N; Cai F
J Child Neurol; 2010 May; 25(5):609-13. PubMed ID: 19779208
[TBL] [Abstract][Full Text] [Related]
31. [Efficacy and tolerability of dose-escalation with generic gabapentin--a multicenter, non-interventional study].
Rejdak K; Lipa A; Kaczyński K; Stelmasiak Z;
Wiad Lek; 2011; 64(2):91-6. PubMed ID: 22026272
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of levetiracetam in children with refractory epilepsy as an add-on trial.
Tonekaboni SH; Ghazavi M; Karimzadeh P; Mahvelati F; Ghofrani M
Epilepsy Res; 2010 Aug; 90(3):273-7. PubMed ID: 20619606
[TBL] [Abstract][Full Text] [Related]
33. Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy.
Berkovic SF; Knowlton RC; Leroy RF; Schiemann J; Falter U;
Neurology; 2007 Oct; 69(18):1751-60. PubMed ID: 17625106
[TBL] [Abstract][Full Text] [Related]
34. Assessment of a dose-response relationship of levetiracetam.
Meencke HJ; Buyle S
Eur J Neurol; 2006 Sep; 13(9):942-6. PubMed ID: 16930358
[TBL] [Abstract][Full Text] [Related]
35. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy.
Chaisewikul R; Privitera MD; Hutton JL; Marson AG
Cochrane Database Syst Rev; 2001; (1):CD001901. PubMed ID: 11279737
[TBL] [Abstract][Full Text] [Related]
36. Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany.
Opp J; Tuxhorn I; May T; Kluger G; Wiemer-Kruel A; Kurlemann G; Gross-Selbeck G; Rating D; Brandl U; Bettendorf U; Härtel C; Korn-Merker E
Seizure; 2005 Oct; 14(7):476-84. PubMed ID: 16182573
[TBL] [Abstract][Full Text] [Related]
37. Economic evaluation of levetiracetam as an add-on therapy in patients with refractory epilepsy.
Blais L; Sheehy O; St-Hilaire JM; Bernier G; Godfroid P; LeLorier JJ
Pharmacoeconomics; 2005; 23(5):493-503. PubMed ID: 15896100
[TBL] [Abstract][Full Text] [Related]
38. Effect of levetiracetam in refractory childhood epilepsy syndromes.
Lagae L; Buyse G; Deconinck A; Ceulemans B
Eur J Paediatr Neurol; 2003; 7(3):123-8. PubMed ID: 12788038
[TBL] [Abstract][Full Text] [Related]
39. Long-term efficacy of levetiracetam for partial seizures.
Abou-Khalil B; Schaich L
Seizure; 2005 Dec; 14(8):577-85. PubMed ID: 16280250
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
Xiao Z; Li JM; Wang XF; Xiao F; Xi ZQ; Lv Y; Sun HB
Eur Neurol; 2009; 61(4):233-9. PubMed ID: 19176965
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
